Hyperpigmentation, uneven skin tone and loss of brightness can make the skin appear dull, tired and less uniform.
These changes may be associated with:
Mesotherapy with Biomimetic Peptides is an injectable treatment used with the aim of improving skin quality, brightness and overall skin appearance.
Depending on the specific treatment protocol and product formulation, it may target:
The goal is not to “whiten” the skin. The goal is to create a more even, luminous and healthier-looking complexion.
Hyperpigmentation is the increased presence of melanin in selected areas of the skin.
It may appear as:
Excess melanin production may be influenced by ultraviolet radiation, hormonal factors and inflammatory processes.
For this reason, the correct treatment should begin with identifying the type and cause of pigmentation.
Biomimetic peptides are short chains of amino acids designed to mimic or influence selected biological signals in the body.
Depending on the peptide and product, they may be used to support:
Peptides are a broad category of compounds and they do not all have the same effect. Their impact on pigmentation depends on the specific molecular structure and mechanism of the product used.
Mesotherapy is a technique in which small amounts of selected active ingredients are injected intradermally into the treatment area.
The aim is to deliver the ingredients directly into the skin layer where they are intended to act.
Depending on the formulation, the treatment plan may aim to improve:
Mesotherapy may be used as part of a broader skin-brightening and pigmentation-management plan in appropriately selected patients.
Melanin production is a complex biological process.
It is influenced by:
When this process becomes overactive or uneven, areas of darker pigmentation may develop.
This is why hyperpigmentation often requires a combination of treatment and daily photoprotection.
Depending on the product used, the treatment protocol may aim to:
It would not be appropriate to promise complete correction of every form of hyperpigmentation.
The result depends mainly on:
In some mesotherapy formulations, biomimetic peptides may be combined with hyaluronic acid.
In this context, hyaluronic acid may contribute mainly to:
Its role here is different from that of a volumising facial filler.
Depending on the indication, treatment may be applied to:
The under-eye area requires particularly careful assessment because of its delicate anatomy.
Not all dark spots have the same depth or underlying mechanism.
In selected cases, mesotherapy may be used as part of a broader skin-brightening programme.
In other cases, the treatment plan may require:
The correct choice depends on the type of pigmentation.
Melasma is a complex and often recurrent form of hyperpigmentation.
It is not simply a superficial dark spot.
It may be associated with:
Mesotherapy may be considered as part of selected treatment protocols, but melasma usually requires a long-term and combination-based approach.
Daily photoprotection is an essential part of treatment.
Skin brightening does not mean changing the natural colour of the skin.
It means improving:
Brighter-looking skin reflects light more evenly because the surface is smoother, the tone is more uniform and the skin quality is improved.
Treatment may be suitable for women and men with:
Final suitability is determined after personal assessment.
In more pronounced or deeper pigmentation, a different or combined approach may be required.
Depending on the case, this may include:
Different treatments may target different stages of melanin production and distribution, which is why combination strategies are often useful.
After assessing the skin, small and controlled intradermal injections of the selected product are performed.
The procedure may take approximately 15–20 minutes, depending on:
The number of treatments is personalised.
In many protocols, an initial course of approximately 2–3 sessions may be recommended.
However:
depend on the specific product and the skin’s response.
The same schedule should not be used automatically for every patient.
The improvement is usually gradual.
Patients may begin to notice:
during the treatment course.
Pigmentation changes may require more time and depend on the depth and cause of the pigmentation.
Downtime is usually limited.
Temporary effects may include:
These usually settle gradually.
After treatment, photoprotection is especially important.
Patients are generally advised to:
Ultraviolet exposure can contribute both to the development and recurrence of hyperpigmentation.
Mesotherapy is a medical injectable procedure and is not completely risk-free.
Possible temporary reactions may include:
Correct product selection, technique and patient selection are therefore important.
Yes.
In many patients, the best result may require a combination approach.
Depending on the concern, treatment may be combined with:
Combination therapy is used only when there is a clear indication.
Hyperpigmentation should not be treated with the same “brightening treatment” in every patient.
Dr Andreas Ioannides, Plastic, Aesthetic & Reconstructive Surgeon, evaluates:
A personalised protocol can then be designed.
We do not treat every dark spot in the same way. We treat the mechanism behind it.
Duration depends on:
Pigmentation may recur, particularly in patients with a predisposition or ongoing sun exposure.
For this reason, patients may need:
The cost of Mesotherapy with Biomimetic Peptides varies according to the personalised treatment plan.
The final price depends on:
The exact price is determined after a personal consultation.
Skin Brightening with Biomimetic Peptides by Dr Andreas Ioannides
The aim is for the skin to appear:
We do not want a different skin colour. We want better skin quality and a clearer, more uniform tone.
During your personal consultation, Dr Andreas Ioannides will assess:
The most appropriate approach may then include:
Mesotherapy with Biomimetic Peptides, medical skincare, chemical peel, laser or a combination of treatments.
It is increased melanin production or accumulation that creates darker areas on the skin.
They are short amino-acid chains used in selected treatments to support specific cellular functions.
In selected patients, it may be used as part of a programme to improve skin tone and overall skin quality.
It may be used as part of selected protocols, but melasma usually requires long-term and combination-based management.
An initial course of approximately 2–3 sessions may be recommended, but the number is personalised.
Usually around 15–20 minutes.
Radiance and skin quality may improve gradually during the treatment course, while pigmentation may require more time.
Not necessarily. Hyperpigmentation may recur, particularly with sun exposure or hormonal influences.
Yes. Consistent photoprotection is an essential part of both treatment and prevention.
In appropriately selected patients and with a suitable product, treatment may be considered for the under-eye area.
Usually limited, although temporary redness, mild swelling or bruising may occur.
The price depends on the product, treatment area, number of sessions and overall treatment plan.